CG'806, a first-in-class FLT3/BTK inhibitor, exerts superior potency against AML cells harboring ITD, TKD and gatekeeper mutated FLT3 or wild-type FLT3.

被引：0
|
作者：
Zhang, Weiguo [1 ]
Zhang, Hongying [2 ]
Local, Andrea [2 ]
Rice, William G. [2 ]
Ly, Charlie J. [1 ]
Yu, Guopan [1 ]
Howell, Stephen B. [3 ]
Andreeff, Michael [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
[2] Aptose Biosci, San Diego, CA USA
[3] UCSD Canc Ctr, La Jolla, CA USA
来源：
CLINICAL CANCER RESEARCH | 2017年 / 23卷 / 24期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
25
引用
收藏
页码：49 / 50
页数：2
相关论文
共 50 条
  • [31] Measurable residual disease status and FLT3 inhibitor therapy in patients with FLT3-ITD mutated AML following allogeneic hematopoietic cell transplantation
    Liang, Emily C.
    Chen, Connie
    Lu, Rong
    Mannis, Gabriel N.
    Muffly, Lori
    BONE MARROW TRANSPLANTATION, 2021, 56 (12) : 3091 - 3093
  • [32] Measurable residual disease status and FLT3 inhibitor therapy in patients with FLT3-ITD mutated AML following allogeneic hematopoietic cell transplantation
    Emily C. Liang
    Connie Chen
    Rong Lu
    Gabriel N. Mannis
    Lori Muffly
    Bone Marrow Transplantation, 2021, 56 : 3091 - 3093
  • [33] Activity of Allosteric, Switch-Pocket, ABL/FLT3 Kinase Inhibitor DCC2036 Against Cultured and Primary AML Progenitors with FLT-ITD or FLT3 Kinase Domain Mutations
    Fiskus, Warren
    Smith, Catherine C.
    Smith, Jacqueline
    Wise, Scott C.
    Lasater, Elisabeth
    Damon, Lauren E.
    Salerno, Sara
    Fleming, Allan
    Reyes, Ruben
    Ganguly, Siddhartha
    Berger, Mark S.
    Rutkoski, Tom J.
    McGuirk, Joseph
    Shah, Neil
    Bhalla, Kapil N.
    BLOOD, 2011, 118 (21) : 1121 - 1121
  • [34] First in Human (FIH) FLT3 and SYK Inhibitor HM43239 Shows Single Agent Activity in Patients (pts) with Relapsed or Refractory (R/R) FLT3 Mutated and Wild-Type Acute Myeloid Leukemia (AML)
    Daver, Naval
    Lee, Kyoo Hyung
    Jung, Chul Won
    Yoon, Sung-Soo
    Arellano, Martha L.
    Yoon, Jiyeon
    Lee, Nora
    Kim, Hyunjin
    Lee, Jaeyeon
    Jonas, Brian A.
    Baek, Seungjae
    BLOOD, 2021, 138
  • [35] Mutated Flt3Lg Provides Reduced Flt3 Recycling Compared to Wild-Type Flt3Lg and Retains the Specificity of Flt3Lg-Based CAR T-Cell Targeting in AML Models
    Maiorova, Varvara
    Mollaev, Murad D.
    Vikhreva, Polina
    Chudakov, Dmitriy M.
    Kibardin, Alexey
    Maschan, Michael A.
    Larin, Sergey
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [36] Correction to: Measurable residual disease status and FLT3 inhibitor therapy in patients with FLT3-ITD mutated AML following allogeneic hematopoietic cell transplantation
    Emily C. Liang
    Connie Chen
    Rong Lu
    Gabriel N. Mannis
    Lori Muffly
    Bone Marrow Transplantation, 2022, 57 : 694 - 694
  • [37] Suppression of leukemia expressing wild-type or ITD-mutant FLT3 receptor by a fully human anti-FLT3 neutralizing antibody
    Li, YW
    Li, HL
    Wang, MN
    Lu, D
    Bassi, R
    Wu, Y
    Zhang, HF
    Balderes, P
    Ludwig, DL
    Pytowski, B
    Kussie, P
    Piloto, O
    Small, D
    Bohlen, P
    Witte, L
    Zhu, ZP
    Hicklin, DJ
    BLOOD, 2004, 104 (04) : 1137 - 1144
  • [38] Suppression of leukemia expressing wild-type or ITD-mutant FLT3 receptor by a human anti-FLT3 neutralizing antibody.
    Li, Y
    Wang, MN
    Li, H
    Lu, D
    Bassi, R
    Zhang, H
    Ludwig, D
    Piloto, O
    Small, D
    Bohlen, P
    Witte, L
    Zhu, Z
    Hicklin, D
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6191S - 6191S
  • [39] Synergy of FLT3 inhibitors and the small molecule inhibitor of LIM kinasel/2 CEL_Amide in FLT3-ITD mutated Acute Myeloblastic Leukemia (AML) cells
    Djamai, Hanane
    Berrou, Jeannig
    Dupont, Melanie
    Kaci, Anna
    Ehlert, Jan Erik
    Weber, Holger
    Baruchel, Andre
    Paublant, Fabrice
    Prudent, Renaud
    Gardin, Claude
    Dombret, Herve
    Braun, Thorsten
    LEUKEMIA RESEARCH, 2021, 100
  • [40] Discovery of PLM-102, a highly potent 3rd generation FLT3 inhibitor, in drug-resistant FLT3-ITD-TKD mutated acute myeloid leukemia
    Park, Jin-Hee
    Lee, Jae-Seon
    Oh, Su-Jin
    Lee, So-Deok
    Choi, Yong June
    Kang, Keon Wook
    Moon, Miran
    Jang, Soo Yeon
    Kim, Myung Jin
    Kim, Yong-Chul
    CANCER RESEARCH, 2023, 83 (07)
12345